These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26273545)

  • 21. Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats.
    Akagi K; Sano M; Ogawa K; Hirose M; Goshima H; Shirai T
    Toxicol Pathol; 2003; 31(4):388-96. PubMed ID: 12851104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells.
    Tang L; Zhang Y
    J Nutr; 2004 Aug; 134(8):2004-10. PubMed ID: 15284390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemopreventive potential of thiol conjugates of isothiocyanates for lung cancer and a urinary biomarker of dietary isothiocyanates.
    Chung FL; Jiao D; Conaway CC; Smith TJ; Yang CS; Yu MC
    J Cell Biochem Suppl; 1997; 27():76-85. PubMed ID: 9591196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk.
    Zhao H; Lin J; Grossman HB; Hernandez LM; Dinney CP; Wu X
    Int J Cancer; 2007 May; 120(10):2208-13. PubMed ID: 17290402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.
    Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J
    Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isothiocyanates: a class of bioactive metabolites with chemopreventive potential.
    Kumar G; Tuli HS; Mittal S; Shandilya JK; Tiwari A; Sandhu SS
    Tumour Biol; 2015 Jun; 36(6):4005-16. PubMed ID: 25835976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the effects of isothiocyanates on chemotherapeutic drugs.
    Minarini A; Milelli A; Fimognari C; Simoni E; Turrini E; Tumiatti V
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):25-38. PubMed ID: 24087843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables.
    Shapiro TA; Fahey JW; Wade KL; Stephenson KK; Talalay P
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1091-100. PubMed ID: 9865427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of predictive models for cancer-specific survival of patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: results from a multicenter retrospective study.
    Nishiyama N; Kitamura H; Hotta H; Takahashi A; Yanase M; Itoh N; Tachiki H; Miyao N; Matsukawa M; Kunishima Y; Taguchi K; Masumori N
    Jpn J Clin Oncol; 2014 Nov; 44(11):1101-8. PubMed ID: 25139163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCG and the treatment of superficial bladder cancer.
    Moss JT; Kadmon D
    DICP; 1991 Dec; 25(12):1355-67. PubMed ID: 1815434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin.
    Baltacı S; Bozlu M; Yıldırım A; Gökçe Mİ; Tinay İ; Aslan G; Can C; Türkeri L; Kuyumcuoğlu U; Mungan A
    BJU Int; 2015 Nov; 116(5):721-6. PubMed ID: 25715815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression.
    Prawan A; Keum YS; Khor TO; Yu S; Nair S; Li W; Hu L; Kong AN
    Pharm Res; 2008 Apr; 25(4):836-44. PubMed ID: 17657593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design.
    Mmeje CO; Guo CC; Shah JB; Navai N; Grossman HB; Dinney CP; Kamat AM
    Eur Urol; 2016 Nov; 70(5):778-785. PubMed ID: 26922408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cruciferous vegetables and cancer prevention.
    Murillo G; Mehta RG
    Nutr Cancer; 2001; 41(1-2):17-28. PubMed ID: 12094621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guérin.
    Kohjimoto Y; Kusumoto H; Nishizawa S; Kikkawa K; Kodama Y; Ko M; Matsumura N; Hara I
    Int J Urol; 2014 Dec; 21(12):1201-7. PubMed ID: 25074295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.
    Guevara A; Salomon L; Allory Y; Ploussard G; de la Taille A; Paul A; Yiou R; Hoznek A; Dahan M; Abbou CC; Vordos D
    J Urol; 2010 Jun; 183(6):2161-4. PubMed ID: 20399454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Nutrition and health". Cruciferous vegetable intake and the risk of human cancer: epidemiological evidence.
    Kim MK; Park JH
    Proc Nutr Soc; 2009 Feb; 68(1):103-10. PubMed ID: 19061536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process.
    Yeary KHK; Clark N; Saad-Harfouche F; Erwin D; Kuliszewski MG; Li Q; McCann SE; Yu H; Lincourt C; Zoellner J; Tang L
    JMIR Cancer; 2022 Feb; 8(1):e32291. PubMed ID: 35166681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.